Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery.
WILMINGTON, Del. , July 11, 2024 /PRNewswire/ — The global induced pluripotent stem cells industry was worth US$ 1.7 billion in 2023. By 2034, it is estimated to reach US$ 4.6 billion, expanding at a CAGR of 9.4% between 2024 and 2034. As reprogramming strategies improve, iPSCs become more feasible for many applications and more attractive to buyers.
The utilization of iPSCs in drug discovery and disease modeling is being accelerated by excessive-throughput screening technologies. Aside from heart disease, liver failure, and diabetes, iPSCs are capable of creating organ replacements. By doing so, the donor organ shortage can be addressed and the impact on affected people can be enhanced. Several wound recuperation treatments are possible with iPSCs, including those that treat excessive burns and chronic ulcers.
Cells from iPSCs can be used to develop new immunotherapies, such as CAR-T mobile treatments for cancer. Depending on the patient’s immune system, these treatment plans may enhance effectiveness and reduce side effects. Besides Parkinson’s disorder, spinal cord injuries, and macular degeneration, iPSCs can also be used to update damaged or diseased cells.
Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30530
Induced Pluripotent Stem Cells Market Report Scope:
Report Coverage |
Details |
Forecast Period |
2024-2034 |
Base Year |
2020-2022 |
Size in 2023 |
US$ 1.7 Bn |
Forecast (Value) in 2034 |
US$ 4.6 Bn |
Growth Rate (CAGR) |
9.4 % |
No. of Pages |
156 Pages |
Segments covered |
By Cell Type, By Application, By End-user |
Global Induced Pluripotent Stem Cells Market: Competitive Landscape
iPSC-based therapies can be commercialized more quickly with partnerships among educational institutions and biotech/pharmaceutical companies. By utilizing global studies networks and consortia, information can be shared, protocols are standardized, and problems can be collectively solved, propelling forward the iPSC industry.
Key Players Profiled
Key Developments
Key Findings of the Market Report
Global Induced Pluripotent Stem Cells Market: Growth Drivers
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30530
Global Induced Pluripotent Stem Cells Market: Regional Landscape
Global Induced Pluripotent Stem Cells Market: Segmentation
Cell Type
Application
End User
Region
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=30530<ype=S
More Trending Report by Transparency Market Research:
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter | Blog | YouTube
Logo: https://healthtechnologynet.com/wp-content/uploads/2024/07/TMR_Logo_Logo-1.jpg
SOURCE Transparency Market Research
By Hari Prasad, Founder and CEO of Yosi Health Hari Prasad In today's digital age,…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Interoperability--Netsmart, a leading provider of healthcare technology solutions and services for community-based…
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Interoperability--Netsmart, a leading provider of healthcare technology solutions and services for community-based…
Innovaccer integrates its Provider Copilot with athenahealth EHR to automate clinical documentation, generate potential diagnoses,…
London, United Kingdom--(Newsfile Corp. - July 11, 2024) - Edison issues report on Custodian Property…
London, United Kingdom--(Newsfile Corp. - July 11, 2024) - Edison issues report on Custodian Property…